HomeHBIO • NASDAQ
Harvard Bioscience, Inc.
$2.72
After Hours:
$2.59
(4.78%)-0.13
Closed: Sep 27, 5:29:57 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$2.66
Day range
$2.67 - $2.73
Year range
$2.50 - $5.56
Market cap
118.62M USD
Avg Volume
101.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
23.10M-19.69%
Operating expense
14.89M-6.21%
Net income
-2.93M-198.67%
Net profit margin
-12.67-271.55%
Earnings per share
0.00-100.00%
EBITDA
128.00K-94.91%
Effective tax rate
10.76%—
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
4.05M-6.38%
Total assets
128.91M-9.79%
Total liabilities
61.66M-8.66%
Total equity
67.25M—
Shares outstanding
43.61M—
Price to book
1.73—
Return on assets
-3.19%—
Return on capital
-3.82%—
Net change in cash
(USD)Jun 2024Y/Y change
Net income
-2.93M-198.67%
Cash from operations
-846.00K-123.82%
Cash from investing
458.00K173.28%
Cash from financing
177.00K107.45%
Net change in cash
-207.00K-138.69%
Free cash flow
-736.75K-136.39%
About
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company has 20 wholly owned subsidiaries. Brands include: AHN Biotechnologie, Biochrom, BioDrop, BTX, CMA, Coulbourn Instruments, Harvard Apparatus, HEKA, Hoefer, Hugo Sachs Elektronik, Multichannel Systems, Panlab, Scie-Plas, and Warner Instruments. Its CEO is James Green. The company has approximately 500 employees, with 300 of those in the USA, and five principal manufacturing facilities in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany. Wikipedia
Founded
1901
Employees
404
Search
Clear search
Close search
Google apps
Main menu